Pacira BioSciences PCRX
NASDAQ PCRX
$36.49 +0.03 (+0.08%)
At close: Nov 10, 2026 · 4:00 PM EST

Pacira BioSciences (PCRX) Non-Current Deferred Tax Liability (2025 - 2026)

Updated

Pacira BioSciences' Non-Current Deferred Tax Liability came in at $4.07 million for Q2 2026, down 11.2% from $4.58 million a year earlier and down 0.6% from the prior quarter.

Analysis

Pacira BioSciences (PCRX) Non-Current Deferred Tax Liability (2025 - 2026) Analysis & Trends

At the end of FY2025, Pacira BioSciences' Non-Current Deferred Tax Liability was $4.21 million.

  • Business Quant data shows PCRX's Non-Current Deferred Tax Liability at $4.09 million (Q1 2026), $4.21 million (Q4 2025) and $4.59 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Pacira BioSciences 1.46 Bn 468.61 Mn 139.42 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 4.03 Mn
Jun 30, 2026 4.07 Mn
Mar 31, 2026 4.09 Mn
Dec 31, 2025 4.21 Mn
Sep 30, 2025 4.59 Mn
Jun 30, 2025 4.58 Mn
Mar 31, 2025 7.00 Mn
API Access

Pacira BioSciences Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=PCRX&period=max&api_key=YOUR_API_KEY